A potentially severe acute respiratory infection caused by the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2).[1] The clinical presentation is generally that of a respiratory infection
with a symptom severity ranging from a mild common cold-like illness, to a severe viral ...
Betacoronavirus/pathogenicity,
Coronavirus Infections/diagnostic imaging,
Coronavirus Infections/complications,
Coronavirus Infections/drug therapy,
Pneumonia, Viral/diagnostic imaging,
Pneumonia, Viral/drug therapy,
Pneumonia, Viral/complications,
Pandemics/statistics & numerical data,
Symptom Flare Up,
Risk Groups,
China/epidemiology,
Healthcare-Associated Pneumonia/diagnosis,
Health Personnel/organization & administration,
Carrier State/transmission,
Infectious Disease Transmission, Vertical/prevention & control
China has managed to control the coronavirus disease (COVID-19) with confinement measurements and treatment strategies, while other countries are struggling to contain the spread. This study discussesthe guidelines related to COVID-19 in China in order to provide important references for other countries
...
Betacoronavirus/drug effects,
Pneumonia, Viral/epidemiology,
Coronavirus Infections/epidemiology,
China/epidemiology,
Pandemics/prevention & control,
Pandemics/statistics & numerical data,
Epidemiological Monitoring,
Health Information Management/methods,
Interferons/therapeutic use,
Lopinavir/therapeutic use,
Ritonavir/therapeutic use,
Ribavirin/therapeutic use,
Chloroquine/therapeutic use,
Coronavirus Infections/drug therapy,
Pneumonia, Viral/drug therapy
Bhimraj, Adarsh;
Morgan, Rebecca L;
Shumaker, Amy Hirsch;
Lavergne, Valery;
Baden, Lindsey;
Cheng, Vincent Chi-Chung;
Edwards, Kathryn M;
Gandhi, Rajesh;
Muller, William J;
O’Horo, John C;
Shoham, Shmuel;
Murad, M. Hassan;
Mustafa, Reem A;
Sultan, Shahnaz;
Falck-Ytter, Yngve.
Develop evidence-based rapid guidelines intended to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID-19....
The purpose of this guideline is to ensure the best treatment for adults with suspected or confirmed pneumonia in the community during the COVID-19 pandemic and best use of NHS resources. We have withdrawn our guideline on diagnosing and managing pneumonia in adults until further notice....
This guideline aims to provide specific, patient-focused recommendations on management and care of people with suspected or confirmed COVID-19. With the exception of chemoprophylaxis for the prevention of infection in people exposed to COVID-19, the guideline does not include other interventions used in ...
Clinical Diagnosis/diagnosis,
Betacoronavirus/drug effects,
Coronavirus Infections/diagnosis,
Pneumonia, Viral/diagnosis,
Hypoxia/diagnosis,
Patient Acuity,
Coronavirus Infections/drug therapy,
Pneumonia, Viral/drug therapy,
Dexamethasone/therapeutic use,
Breast Feeding,
Antiviral Agents/therapeutic use,
Hydroxychloroquine/therapeutic use,
Colchicine/therapeutic use,
Plasma/immunology,
Darunavir/therapeutic use,
Interferons/therapeutic use,
Evidence-Based Practice/methods